Care Models to Improve Pain and Reduce Opioids Among Patients Prescribed Long-Term Opioid Therapy
JAMA Internal Medicine · 01.02.2025 · 185 (2) · 208
DOI: 10.1001/jamainternmed.2024.6683 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JAMA Internal Medicine, erschienen am 01.02.2025. Verfasst von Erin E Krebs und 41 weiteren Autor:innen. Beteiligte Einrichtung: Minneapolis VA Health Care System, Minneapolis, Minnesota. Hauptthemen laut MEDLINE: Analgesics, Opioid, Chronic Pain, Pain Management. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS.
Abstract (Originalsprache)
Importance Patients prescribed long-term opioid therapy for chronic pain often experience unrelieved pain, poor quality of life, and serious adverse events.
Objective
To compare the effects of integrated pain team (IPT) vs pharmacist collaborative management (PCM) on pain and opioid dosage. Design, Setting, and Participants This study was a pragmatic multisite 12-month randomized comparative effectiveness trial with masked outcome assessment. Patients were recruited from October 2017 to March 2021; follow-up was completed June 2022. The study sites were Veterans Affairs primary care clinics. Eligible patients had moderate to severe chronic pain despite long-term opioid therapy (≥20 mg/d for at least 3 months).
Interventions
IPT involved interdisciplinary pain care planning, visits throughout 12 months with medical and mental health clinicians, and emphasis on nondrug therapies and motivational interviewing. PCM was a collaborative care intervention involving visits throughout 12 months with a clinical pharmacist care manager who conducted structured monitoring and medication optimization. Both interventions provided individualized pain care and opioid tapering recommendations to patients. Main Outcomes and Measures The primary outcome was pain response (≥30% decrease in Brief Pain Inventory total score) at 12 months. The main secondary outcome was 50% or greater reduction in opioid daily dosage at 12 months.
Results
A total of 820 patients were randomized to IPT (n = 411) or PCM (n = 409). Participants’ mean (SD) age was 62.2 (10.6) years, and 709 (86.5%) were male. A pain response was achieved in 58/350 patients in the IPT group (16.4%) vs 54/362 patients in the PCM group (14.9%) (odds ratio, 1.11 [95% CI, 0.74-1.67]; P = .61). A 50% opioid dose reduction was achieved in 102/403 patients in the IPT group (25.3%) vs 98/399 patients in the PCM group (24.6%) (odds ratio, 1.03 [95% CI, 0.75-1.42]; P = .85). Over 12 months, the mean (SD) Brief Pain Inventory total score improved from 6.7 (1.5) points to 6.1 (1.8) points ( P < .001) in IPT and from 6.6 (1.6) points to 6.0 (1.9) points ( P < .001) in PCM (between-group P = .82). Over 12 months, mean (SD) opioid daily dosage decreased from 80.8 (74.2) mg/d to 54.2 (65.0) mg/d in IPT ( P < .001) and from 74.5 (56.9) mg/d to 52.8 (51.9) mg/d ( P < .001) in PCM (between-group P = .22). Conclusions and Relevance Outcomes in this randomized clinical trial did not differ between groups; both had small improvements in pain and substantial reductions in opioid dosage. Trial Registration ClinicalTrials.gov Identifier: NCT03026790
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Minneapolis VA Health Care System, Minneapolis, Minnesota.
- Division of General Internal Medicine, University of Minnesota Medical School, Minneapolis.
- VA Connecticut Healthcare System, West Haven.
- Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
- Department of Medicine, University of Minnesota Medical School, Minneapolis.
- Division of Epidemiology & Community Health, University of Minnesota School of Public Health, Minneapolis.
Förderung
- NCATS NIH HHS
Zitieren
APA
Krebs, E. E., Becker, W. C., Nelson, D. B., DeRonne, B. M., Jensen, A. C., Kats, A. M., Morasco, B. J., Frank, J. W., Makris, U. E., Allen, K. D., Naylor, J. C., Mixon, A. S., Bohnert, A., Reznik, T. E., Painter, J. T., Hudson, T. J., Hagedorn, H. J., Manuel, J. K., Borsari, B., …, & VOICE Study Group (2025). Care Models to Improve Pain and Reduce Opioids Among Patients Prescribed Long-Term Opioid Therapy. JAMA Internal Medicine, 185(2), 208. https://doi.org/10.1001/jamainternmed.2024.6683
Vancouver
Krebs EE, Becker WC, Nelson DB, DeRonne BM, Jensen AC, Kats AM, et al. Care Models to Improve Pain and Reduce Opioids Among Patients Prescribed Long-Term Opioid Therapy. JAMA Internal Medicine. 2025;185(2):208. doi:10.1001/jamainternmed.2024.6683
BibTeX
@article{Krebs2025,
author = {Krebs, Erin E and Becker, William C and Nelson, David B and DeRonne, Beth M and Jensen, Agnes C and Kats, Allyson M and Morasco, Benjamin J and Frank, Joseph W and Makris, Una E and Allen, Kelli D and Naylor, Jennifer C and Mixon, Amanda S and Bohnert, Amy and Reznik, Thomas E and Painter, Jacob T and Hudson, Teresa J and Hagedorn, Hildi J and Manuel, Jennifer K and Borsari, Brian and Purcell, Natalie and Hammett, Patrick and Amundson, Erin C and Kerns, Robert D and Barbosa, Monica R and Garvey, Caitlin and Jones, Elzie J and Noh, Maureen Y and Okere, Jennifer B and Bhushan, Sujata and Pinsonnault, John and Williams, Beth E and Herbst, Ellen and Lagisetty, Pooja and Librodo, Sara and Mapara, Payal S and Son, Elizabeth and Tat, Christina and Marraffa, Rebecca A and Seys, Randy L and Baxley, Catherine and Seal, Karen H and VOICE Study Group, VOICE Study Group},
title = {Care Models to Improve Pain and Reduce Opioids Among Patients Prescribed Long-Term Opioid Therapy},
journal = {JAMA Internal Medicine},
year = {2025},
volume = {185},
number = {2},
pages = {208},
doi = {10.1001/jamainternmed.2024.6683}
}
EUVIMED